Literature DB >> 3039542

X-ray characterisation of normal and neoplastic breast tissues.

P C Johns, M J Yaffe.   

Abstract

Normal and neoplastic breast tissues have been characterised in terms of x-ray attenuation. Samples of normal fat and fibrous tissue were obtained from reduction mammoplasty and autopsy, and infiltrating duct carcinoma specimens from mastectomy and lumpectomy. A high-purity germanium spectroscopy system and a beam of 120 kV constant potential x-rays were used to determine the linear attenuation coefficient from 18 to 110 keV. Densities were determined from buoyancy measurements and were used to obtain mass attenuation coefficients. Infiltrating duct carcinomas and fat are well distinguished by x-ray attenuation. For photon energies used for film-screen mammography, infiltrating duct carcinomas are more attenuating than fibrous tissue. Above 31 keV, the ranges of attenuation of the two tissue types overlap. The attenuation coefficients of tissues have been concisely represented by equivalent thicknesses of lucite and aluminium. Analysis based on the average attenuation properties of tissues indicates that dual-energy mammography, using an ideal imaging system, would require 0.06 cGy to provide images in which 1 cm infiltrating duct carcinomas are displayed with a signal to noise ratio of 5 against a background over which the fat/fibrous contrast has been suppressed. This dose is similar to that currently used in conventional film-screen mammography.

Entities:  

Mesh:

Year:  1987        PMID: 3039542     DOI: 10.1088/0031-9155/32/6/002

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  74 in total

1.  An analysis of the mechanical parameters used for finite element compression of a high-resolution 3D breast phantom.

Authors:  Christina M L Hsu; Mark L Palmeri; W Paul Segars; Alexander I Veress; James T Dobbins
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

2.  A statistically defined anthropomorphic software breast phantom.

Authors:  Beverly A Lau; Ingrid Reiser; Robert M Nishikawa; Predrag R Bakic
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

3.  Task-based assessment of breast tomosynthesis: effect of acquisition parameters and quantum noise.

Authors:  I Reiser; R M Nishikawa
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

Review 4.  Breast tissue composition and susceptibility to breast cancer.

Authors:  Norman F Boyd; Lisa J Martin; Michael Bronskill; Martin J Yaffe; Neb Duric; Salomon Minkin
Journal:  J Natl Cancer Inst       Date:  2010-07-08       Impact factor: 13.506

5.  Model predictions for the wide-angle x-ray scatter signals of healthy and malignant breast duct biopsies.

Authors:  Robert J LeClair; Andrew Ferreira; Nancy McDonald; Curtis Laamanen; Robert Y Tang
Journal:  J Med Imaging (Bellingham)       Date:  2015-10-23

6.  Investigation of x-ray spectra for iodinated contrast-enhanced dedicated breast CT.

Authors:  Stephen J Glick; Andrey Makeev
Journal:  J Med Imaging (Bellingham)       Date:  2017-01-26

7.  Visibility of microcalcification in cone beam breast CT: effects of X-ray tube voltage and radiation dose.

Authors:  Chao-Jen Lai; Chris C Shaw; Lingyun Chen; Mustafa C Altunbas; Xinming Liu; Tao Han; Tianpeng Wang; Wei T Yang; Gary J Whitman; Shu-Ju Tu
Journal:  Med Phys       Date:  2007-07       Impact factor: 4.071

8.  Breast tissue characterization with photon-counting spectral CT imaging: a postmortem breast study.

Authors:  Huanjun Ding; Michael J Klopfer; Justin L Ducote; Fumitaro Masaki; Sabee Molloi
Journal:  Radiology       Date:  2014-05-07       Impact factor: 11.105

9.  Quantitative contrast-enhanced spectral mammography based on photon-counting detectors: A feasibility study.

Authors:  Huanjun Ding; Sabee Molloi
Journal:  Med Phys       Date:  2017-06-28       Impact factor: 4.071

10.  Role of equalisation mammography of dense breasts.

Authors:  D B Plewes; J M Sabol; I Soutar; A Chevrier; R Shumak
Journal:  Med Biol Eng Comput       Date:  1995-03       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.